Abrdn PLC Neogenomics Inc Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Abrdn PLC holds 413,098 shares of NEO stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
413,098
Previous 413,098
-0.0%
Holding current value
$2.27 Million
Previous $3.92 Million
22.98%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
280Shares Held
126MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$108 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$78.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$36.9 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$33.2 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$31.5 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $691M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...